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The aim of this study was to test the potential of high molecular weight
exopolysaccharide (EPS) produced by the putative probiotic strain Lactobacillus
paraplantarum BGCG11 (EPS CG11) to alleviate inflammatory pain in Wistar rats.
The EPS CG11 was isolated from bacterial surface and was subjected to Fourier-
transform infrared spectroscopy (FTIR) and thermal analysis. FTIR spectra confirmed the
polysaccharide structure of isolated sample, while the thermal methods revealed good
thermal properties of the polymer. The antihyperalgesic and antiedematous effects of
the EPS CG11 were examined in the rat model of inflammation induced by carrageenan
injection in hind paw. The results showed that the intraperitoneal administration of EPS
CG11 produced a significant decrease in pain sensations (mechanical hyperalgesia)
and a paw swelling in a dose-dependent manner as it was measured using Von
Frey anesthesiometer and plethysmometer, respectively. These effects were followed
by a decreased expression of IL-1β and iNOS mRNAs in rat’s paw tissue suggesting
that the antihyperalgesic and antiedematous effects of the EPS CG11 are related
to the suppression of inflammatory response. Additionally, we demonstrated that
EPS CG11 exhibits immunosuppressive properties in the peritonitis model induced
by carrageenan. Expression levels of pro-inflammatory mediators IL-1β, TNF-α and
iNOS were decreased, together with the enhanced secretion of anti-inflammatory IL-10
and IL-6 cytokines, while neutrophil infiltration was not changed. To the best of our
knowledge, this is the first study which reports an antihyperalgesic effect as the novel
property of bacterial EPSs. Given the high demands of pharmaceutical industry for
the replacement of commonly used analgesics due to numerous side effects, this
study describes a promising natural compound for the future pharmacological testing in
the area.
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INTRODUCTION
Management of pain caused either by abnormal excitation of
peripheral sensory neurons or by existing local inflammation,
currently leads the list of mostly demanded drugs at the
pharmaceutical market. Inflammatory pain results from the
increased excitation of peripheral nociceptive sensory neurons as
a consequence of the accumulation of inflammatory mediators
(Linley et al., 2010). Every tissue injury is followed by
production of different endogenous factors released from
activated nociceptors, tissue-resident sentinel cells (endothelial
cells, keratinocytes, and fibroblasts) and recruited immune cells
(mast cells, basophils, platelets, macrophages, and neutrophils).
These factors represent a wide spectrum of signaling molecules
including bradykinin, histamine, serotonin, ions (K+, H+), ATP,
nitric oxide (NO), prostaglandins, pro-inflammatory cytokines
(TNF-α, IL-1β, and IL-6) and growth factors (Basbaum et al.,
2009; Ji et al., 2014). Some of these factors act directly on
the peripheral sensory neurons affecting the specific receptors
and producing a spontaneous pain, while others activate
immune cells and stimulate the release of additional pain-
inducing agents (Kidd and Urban, 2001). IL-1β and TNF-α
represent the first cytokines formed in injured tissue and
targeting these cytokines with appropriate antibodies could
delay the onset of the inflammatory pain (Zhang and An,
2007). However, in spite of a major breakthrough of antibody
immunotherapy, the development of novel most cost-effective
drugs with potential to modulate the production of pro-
inflammatory cytokines remains a significant goal in pain
management.
Among the plenty of natural compounds, polysaccharides
have been recognized as molecules with anti-nociceptive and
anti-inflammatory activity. Bacteria from Lactobacillus genus
possess the ability to produce different kind of polysaccharides
attached to the cell surface. These polysaccharides can be
associated to the bacterial cell wall forming a capsule (capsular
polysaccharides) or can be loosely attached or secreted into
the bacterial environment [exopolysaccharides (EPSs)]
(Caggianiello et al., 2016). Lactobacilli produce both homo-
and heteroexopolysaccharides exhibiting a great structural
variability with different physico-chemical and biological
properties (Badel et al., 2011). Beside the well-established
role of EPSs in the maintenance of bacterial homeostasis and
survival, the number of studies reporting the health promoting
potential of EPSs has increased extensively. For instance,
EPSs have been identified as the inducers of apoptosis and
autophagy in the cancer cell lines (Kim et al., 2010; Di et al.,
2017). Moreover, the findings of Maeda et al. (2004) revealed
the effects of EPS on blood pressure and blood glucose levels,
while Tang et al. (2017) demonstrated its antioxidant activity.
However, one of the major pharmacological effect of EPSs
lies in the modulation of immune system response and its
diverse composition dictates different immunomodulatory
properties (Jones et al., 2014). Given the above literature data
regarding the application of EPSs in the regulation of different
pathophysiological conditions, in this study, we intended to
evaluate the eventual antihyperalgesic and/or antiedematous
potential of the EPS isolated from Lactobacillus paraplantarum
BGCG11 strain.
Lactobacillus paraplantarum BGCG11, isolated from a soft,
white, artisanal cheese, produces a high-molecular-weight EPS
(around 2 × 106 Da) composed of glucose (75.7%), rhamnose
(20.5%), galactose (2.1%), and mannose (1.7%) (Cerning et al.,
1994; Zivkovic et al., 2015). Our previous studies showed that
L. paraplantarum BGCG11 strain exhibits an anti-inflammatory
effect on peripheral blood mononuclear cells (PBMC), unlike
the non-EPS derivative strains which induce the higher pro-
inflammatory response of PBMC. Furthermore, the upregulation
of IL-10, anti-inflammatory cytokine production was detected
in the culture of PBMC treated with purified EPS CG11
(Nikolic et al., 2012). Hence, it could be hypothesized that the
inflammation of different etiology could be controlled by EPS
CG11 treatment.
MATERIALS AND METHODS
Bacterial Strain and Culture Condition
Lactobacillus paraplantarum strain BGCG11 from the laboratory
collection of the Laboratory of Molecular Microbiology, Institute
of Molecular Genetics and Genetic Engineering, University
of Belgrade, Serbia was used in this study. The strain was
grown overnight at 30◦C in deMan-Rogosa-Sharpe (MRS) broth
(Merck, Darmstadt, Germany).
EPS Isolation and Purification
The EPS produced by BGCG11 strain was isolated by
spreading 200 µl of overnight bacterial culture on 100
MRS plates containing 1.7% of agar (Torlak, Belgrade) in
order to increase the yield of the polymer. Plates were
incubated for 48 h at 30◦C. After incubation time, EPS
extraction was performed according to the protocol provided
by Ruas-Madiedo et al. (2006), consisting in an initial
extraction, ethanol precipitation and dialysis. Afterward, to
reduce the content of nucleic acids and proteins, crude
EPS fraction was further purified by the addition of DNAse
type-I (Sigma–Aldrich, final concentration 2.5 µg/ml) for
6 h at 37◦C, followed by Pronase E (Sigma–Aldrich, final
concentration 50 µg/ml) treatment overnight at 37◦C. Finally,
the precipitation of remaining proteins was done by the
addition of trichloroacetic acid (12% final concentration) at
room temperature for 30 min. The mixture was centrifuged
(10000 rpm, 20 min, 4◦C) and the supernatant was collected
and its pH adjusted to 7. The supernatant was dialyzed using
12–14 KDa molecular mass cutoff dialysis bag (Sigma–Aldrich)
and finally lyophilized (Alpha 1–4 LSC Plus Freeze dryer, Martin
Christ, Germany).
Microscopy Analysis
The sample surface was observed by the OPTICA B-500MET
light microscope (Optica SRL, Italy) after lyophilization and
with no further preparation, by transmitted polarized and
ordinary (not polarized) light. The images were collected
with OPTIKAM PRO 8LT-4083.18 camera equipped with
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scientific-grade CCD sensor. Although not so often employed
for studying biopolymer structures, the light microscopy
had demonstrated to have the potential for being used
as a tool in such characterization (Sanghoon and Willett,
2001).
Fourier-Transform Infrared Spectroscopy
(FTIR)
The qualitative analysis of the sample was performed by
FTIR spectroscopy, which has been frequently used as a tool
for detection of the structural characteristics of biopolymers
(Ramesan and Surya, 2016). FTIR spectra of the samples were
recorded in the range of 400–4000 cm−1 using a Thermo
Scientific Nicolet iS10 Spectrometer equipped with Smart iTX
accessory (Thermo Scientific, Inc., United States) at 4 cm−1
spectral resolution and 32 scans. FTIR spectra were collected in
the reflection mode with the built-in diamond attenuated total
reflectance (ATR) sampling technique. The OMNIC Software was
used for the acquisition, processing, analyzing, and managing
FTIR data in a graphical environment.
Thermal Analysis
Thermal behavior of the sample was analyzed on two separate
devices. Thermal stability and decomposition were determined
using Setsys Evolution instrument (SETARAM, France). The
sample was placed in alumina crucible (volume 100 µl) and
subjected to the heating regime of 10◦C/min from ambient
temperature up to 900◦C in the atmosphere of synthetic
air (flow rate 50 ml/min). The corresponding differential
thermogravimetric (DTG) signal and the mass loss were obtained
by help of the CALISTO software taking the first derivative of
the thermogravimetric analysis (TGA) signal and calculating the
vertical difference on the marked horizontal points.
The potential phase transitions and the other thermally
induced phenomena characteristic for polysaccharides like
melting, gelatinization, swelling, or dehydration were further
analyzed on the SETARAM apparatus DSC EVO 131. The
accurately measured sample was placed in 30 µl sealed aluminum
pans. The sample was heated/cooled from room temperature up
to 200◦C with a heating rate of 10◦C/min and using nitrogen as a
purge gas. An empty aluminum pan was used as a reference.
Animals
Male Wistar rats (n = 39, weighing 200–250 g) used in
the experiments were purchased from the Military Medical
Academy Breeding Farm, Belgrade, Serbia. The rats were
housed in the temperature-controlled room (22 ± 1◦C) with
food and water available ad libitum under a 12 h light/dark
cycle. This study was carried out in accordance with the
recommendations of Directive 2010/63/EU on the protection
of animals used for scientific purposes, Institutional Animal
Care and The Use Committee of the Faculty of Pharmacy,
University of Belgrade, Serbia. The protocol was approved by
the Institutional Animal Care and The Use Committee of the
Faculty of Pharmacy, University of Belgrade, Serbia (No. 323-07-
1193/2014-05).
Induction of Paw Inflammation and
Treatment Administration
The rats were randomly divided into four groups (n = 6) and
inflammation of the rat’s hind paw was induced by an intraplantar
(i.pl.) injection of carrageenan λ (Sigma–Aldrich; 0.1 ml/paw;
1% m/V, dispersed in 0.9% NaCl) (Morris, 2003; Stepanovic´-
Petrovic´, 2012). Carrageenan-induced inflammation is followed
by the development of edema and nociceptive hypersensitivity
(hyperalgesia) (Morris, 2003; Vivancos et al., 2004; Stepanovic´-
Petrovic´, 2012) and was used to test both the antiedematous
and antihyperalgesic activity of lyophilized EPS CG11. The rats
were treated intraperitoneally (i.p.), in a volume of 2 ml/kg,
with 0.9% NaCl (group I, untreated control) or 3, 4, and
5 mg/kg of lyophilized EPS CG11 dissolved in 0.9% NaCl
(groups II, III, and IV, respectively), 60 min before carrageenan
injection.
Antiedematous Activity Assessment
Antiedematous activity was assessed with a plethysmometer
(Ugo Basile, Comerio, Italy), by measuring the increase in paw
volume following carrageenan injection, as described previously
(Stepanovic´-Petrovic´, 2012). The basal paw volumes were
measured before the treatment application. The post-treatment
paw volumes were measured in seven time points, during 300 min
after the carrageenan injection. The results are expressed as the
difference (dV) between the post-treatment and the basal paw
volumes according to the following formula:
dV = post-treatment volume of the inflamed paw (ml)−
basal volume of the same paw (ml).
The measurements were repeated two times at each time point
and the average dV of each rat was used for further calculations.
The percentage of antiedematous activity (%AE) was calculated
according to the following formula (Stepanovic´-Petrovic´, 2012):
%AE = [(control group average dV − dV of each rat in the
test group)\ (control group average dV)] × 100.
Antihyperalgesic Activity Assessment
The development of mechanical hyperalgesia following
carrageenan injection and the antihyperalgesic effects of
EPS CG11 were assessed by measuring paw withdrawal
thresholds (PWTs) using an electronic Von Frey anesthesiometer
(IITC Life Science, Woodland Hills, CA, United States) as
described previously (Vivancos et al., 2004). The rats were
placed in transparent boxes on the top of a metal grid and
allowed to acclimatize for 30 min before testing. A plastic,
semi-flexible filament coupled with a force transducer was used
to deliver the mechanical stimulus. The tip of the filament
was applied perpendicularly to the plantar surface of the right
hind paw and the pressure was gradually increased until the
rat withdrew its paw (the force, in grams, required to elicit
brisk paw withdrawal was recorded on a digital screen). The
average of four PWT measurements was used for further
calculations.
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Basal PWTs were measured before treatment application.
Post-treatment PWTs were measured in seven time points,
during 300 min after the induction of inflammation. The results
are expressed as the difference (df) between basal and post-
treatment PWTs according to the following formula (Vivancos
et al., 2004):
df = basal PWT before the induction of inflammation (g)−
post-treatment PWT after the induction of inflammation (g).
The percentage of antihyperalgesic activity (%AH) was
calculated according to the following formula (Stepanovic´-
Petrovic´, 2012):
%AH = [(control group average df − df of each rat in the
test group)/(control group average df)] × 100.
Immediately after the experiments animals were sacrificed using
CO2 gas. The paws were collected, snap-frozen in liquid nitrogen
and stored at−80◦C until further analysis.
Peritonitis Model
The evaluation of immunological effect of the EPS CG11 was
determined in peritonitis model induced by i.p. injection of
1% carrageenan solution as previously described by Barth et al.
(2016). One hour before carrageenan administration animals
were treated i.p. with saline (n = 5, positive control) or
5 mg/kg of lyophilized EPS CG11 (n = 5, treatment group).
Additionally, one group of animals was treated i.p. only with
saline as negative control (n = 5). The rats were killed
4 h later and the peritoneal cavity was washed with 4 ml
of RPMI medium (Gibco, Life Technologies) supplemented
with 10% fetal bovine serum (FBS, Gibco, Life Technologies)
to collect peritoneal cells and released cytokines. The equal
volume of injected media was recovered from the peritoneal
cavity in all experimental groups (V = 3 ml). The total cell
number was determined in the Neubauer chamber in the
Türk solution to exclude erythrocytes counting. The results are
presented as the number of cells per ml of peritoneal fluid. The
peritoneal fluid were further centrifuged (2000 rpm, 5 min) and
supernatants were collected and stored on −20◦C for cytokines
determination, while pelleted cells were frozen on −80◦C for
RNA extraction.
Enzyme-Linked Immunosorbent Assay
The levels of TNF-α, IL-6, and IL-10 were measured in the
peritoneal fluid using a sandwich enzyme-linked immunosorbent
assay (ELISA) according to the manufacturer’s instructions.
ELISA kits for TNF-α and IL-6 were obtained from R&D Systems
(Minneapolis, MN, United States) while IL-10 was from Novex
Life Technologies. The results are presented as the concentrations
of cytokines per ml of peritoneal fluid.
Quantitative Real-Time PCR
The total RNA extraction from the rat paws and peritoneal
cells was performed as previously described by Lukic et al.
(2013). Briefly, the frozen paws were pulverized in liquid
nitrogen using mortar and pestle and resuspended in denaturing
solution, while peritoneal cells were directly resuspended
in denaturing solution. Afterward, acid phenol (pH = 4)
extraction were performed followed by isopropanol precipitation.
The acid phenol extraction step was repeated two times.
Reversed transcription was done using 1 µg of isolated
RNA as a template (200 ng of RNA from peritoneal cells),
according to the instructions of the enzyme manufacturer
(Thermo Scientific). Random hexamers (Applied Biosystems)
and RiboLock RNase inhibitor (Thermo Scientific) were used
in the reactions. Synthesized cDNA was further amplified
in 7500 real-time PCR system (Applied Biosystems) using
KAPA SYBR Fast qPCR Kit (KAPA Biosystems, Wilmington,
MA, United States) under the following conditions: 3 min
at 95◦C activation, 40 cycles of 15 s at 95◦C and 60 s at
60◦C. The results were normalized to endogenous controls
(β-actin or GAPDH) and expressed as relative target abundance
using the 2−11Ct method. Primers used in the study are
listed in Table 1. All primers were purchased from Thermo
Scientific.
Western Blot
Protein lysates were obtained from a paw tissue previously
pulverized in liquid nitrogen using RIPA buffer and subsequently
subjected to Western blot analysis as described by Dinic et al.
(2017). Briefly, the extracted proteins (20 µg) were separated
on 12% SDS–PAGE and transferred to 0.2 mm nitrocellulose
membrane (GE Healthcare) using Bio-Rad Mini trans-blot
system (Bio-Rad, Hercules, CA, United States). The membranes
were incubated for 2 h with anti-myeloperoxidase (MPO)
antibody (1:1000; Abcam) and anti-β-actin (1:1000; Thermo
Scientific). The membranes were washed and incubated with
appropriate HPR-conjugated secondary antibodies (goat anti-
rabbit; 1:10000; Thermo Scientific and goat anti-mouse; 1:10000;
Amersham Biosciences, Piscataway, NJ, United States) for 1 h
at room temperature. Proteins were detected by enhanced
chemiluminescence (Immobilon Western, Merck Millipore).
TABLE 1 | The list of primers used in this study.
Primer name Primer sequence 5′–3′ Reference
β-Actin forward AGCCATGTACGTAGCCATCC Mousavi et al., 2009
β-Actin reverse CTCTCAGCTGTGGTGGTGAA
GAPDH forward CCCCCAATGTATCCGTTGTG Tanga et al., 2004
GAPDH reverse TAGCCCAGGATGCCCTTTAGT
TNF-α forward AAATGGGCTCCCTCTCATCAGTTC Peinnequin et al., 2004
TNF-α reverse TCTGCTTGGTGGTTTGCTACGAC
IL1-β forward GGAAGGCAGTGTCACTCATTGTG Tilleux et al., 2007
IL1-β reverse GGTCCTCATCCTGGAAGCTCC
IL-6 forward GTGGCTAAGGACCAAGACCA Lugrin et al., 2015
IL-6 reverse ACCACAGTGAGGAATGTCCA
iNOS forward GACCAGAAACTGTCTCACCTG Choi et al., 2012
iNOS reverse CGAACATCGAACGTCTCACA
CD14 forward TCTGAGGGTCCTGGTCAACA Lukic et al., 2017
CD14 reverse TTGTGAGCACCGATGGACAA
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The intensity of the bands was quantified using ImageJ
software. The results were normalized to β-actin loading
control.
Statistical Analysis
The statistical analysis was performed using SigmaPlot 11 (Systat
Software, Inc., Richmond, CA, United States) and SPSS 20.0 for
Windows. All the results are presented as means± standard error
of the means (SEM). The differences between corresponding
group means in antiedematous/antihyperalgesic activity
experiment were assessed by using a two-way repeated-measures
ANOVA followed by Tukey HSD test for post hoc comparisons
(the type of treatment was the between-subject factor and
time after treatment application was the within-subject factor).
One-way ANOVA with the Tukey’s post hoc test were used to
compare multiple groups in all other experiments. A p value less
than 0.05 was considered statistically significant. Graphs were
drawn in the GraphPad Prism software (trial version).
RESULTS
Microscopy and FTIR Analysis of the EPS
CG11
The representative image shows that polysaccharides chains
are arranged in the form of fibers with a diameter of around
few microns. These fibers are further entangled with each
other in a three-dimensional mesh. Such three-dimensional
structure is not unusual since, among other biopolymers, the
polysaccharides show the greatest chemical and structural variety
(Urbani et al., 2012). This wide chemical and structural variability
can be explained by the multiple hydroxyl functionality of
the five- and six-carbon sugars. From the literature it is
known, the replacement of one or more of such sugar
hydroxyl functionalities by amine, ester, carboxylate, phosphate
or sulfonate groups, leads to the frequent occurrence of tree-
like branching and to the huge number of possible polymeric
conformations of different solution behavior (Aspinall, 1982;
Urbani et al., 2012). From the Figure 1A also randomly
distributed spherical particles can be seen within the polymer
network.
The analysis of the FTIR spectra was used to identify purified
material as the polysaccharide by qualitative assessment of
functional groups and chemical bonds present in the specimen.
The representative FTIR spectrum is presented in Figure 1B.
The analysis revealed the presence of carboxyl, hydroxyl, and
amide groups corresponding to a typical polysaccharide. The
spectrum has a broad absorption band at 3313.56 cm−1
assigned to –OH or –NH vibrations (Silverstein et al., 1981;
Coates, 2000). The data from the literature revealed that
the polysaccharides contain a significant number of hydroxyl
groups, which exhibit an intense broad stretching vibration
in that region (Nataraj et al., 2008). This is the characteristic
absorption band of the carbohydrate ring and is responsible
for the water solubility of polysaccharides. A small band
at 2939 and 2876 cm−1 also points to C–H stretching
vibrations of –CH2 methylene and –CH3 methyl groups
FIGURE 1 | Representative light microscopy image (A) and
Fourier-transformed infrared (FT-IR) spectrum (B) of the exopolysaccharide
CG11 (EPS CG11) isolated from Lactobacillus paraplantarum BGCG11 strain.
commonly existing in hexoses, like glucose or galactose or
deoxyhexose, like rhamnose. The band at 2362.18 cm−1
corresponds to the C–O stretch vibration. The band at
1636.99 cm−1 is associated with C = O group, while the band
at 1038.90 cm−1 belongs to C–O stretch vibration or phosphate
functional group (P-O-C stretch) and it is commonly associated
with alcohols, ethers or polysaccharides (Coates, 2000). The
strongest absorption band at 1038.90 cm−1 indicates that the
substance is a polysaccharide (Nataraj et al., 2008). Also from
the literature, it is known that polysaccharides generally consist of
monosaccharides and some non-carbohydrate substituents (such
as acetate, pyruvate, succinate, and phosphate) (Lembre et al.,
2012). Apart from those peaks, in the spectra of our sample, no
other peaks can be identified.
Thermal Properties of the EPS CG11
Substances that undergo through high temperature
pharmaceutical processes must possess suitable thermal
properties in order to avoid some structural deformation,
degradation, or melting due to absorption or emission of
the heat. Therefore, the TGA analysis was carried out to
determine the thermal stability and decomposition pattern
of the EPS CG11. According to Chowdhury et al. (2011),
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FIGURE 2 | The thermal behavior assessment of exopolysaccharide CG11
(EPS CG11) isolated from L. paraplantarum BGCG11 strain. Diagrams
represent TG/DTA (A), TG/DTG (B), and DSC (C) curves.
polysaccharides undergo degradation through several distinct
phases. Figures 2A,B show TG/DTA and TG/DTG thermograms
of isolated EPS CG11. At the beginning, weight loss occurs
because of desorption of physically absorbed water which is
then followed by the removal of structural water or dehydration.
In our sample, these two processes are combined and take
place in the temperature interval 46–215◦C. The endothermic
profile of DTA signal confirmed this theory. The calculated
weight loss (1m) for this stage is 11.5% of initial mass. The
next step involves the decomposition of material which includes
breaking down of C–O, C–C bonds mainly followed by the
evaporation of CO, CO2, and H2O. In this decomposition
process the total mass loss is 58.1% starting from 215 to
663◦C with the highest rate at 250.3◦C. Based on DTG
signal, the decomposition can be further separated in three
stages: (i) 215–264 with 1m = 16.3%; (ii) 264–409◦C with
1m = 27.6%; and (iii) 409–663◦C with 1m = 14.2%. On
the DTA curve, the decomposition is expressed through
exothermic shoulder, which at the same time indicates the
complexity of the process itself. In the remaining part of TGA
curve, there is a small change in the mass of 3.1%, starting
from 680 to 895◦C after which the signal becomes stable.
After completing the analysis, it is observed a significant
amount of solid residue which could be correlated with a
presence of cations (Na+, K+, and Ca2+) or phosphoric
groups.
The differential scanning calorimetric (DSC) analysis was
done in a lower temperature region, i.e., up to 200◦C where
the sample is stabile according to the TGA analysis. The
DSC signal shown on Figure 2C reveals the absorption
of heat at three temperatures 79.2, 121.9, and 168.1◦C,
respectively. The values of associated enthalpies (7–11 J/g)
exclude the possibility for consideration of these events
as melting processes. Also gelatinization requires a larger
amount of water in the system. Most likely these endothermic
events could be attributed to the removal of moisture
and dehydration through evaporation, since EPS is a very
hydrophilic molecule. To confirm this assumption, after cooling,
the sample was subjected to the second heating regime
under the same conditions. The endothermic event at higher
temperature did not occur during the second run. This
observation indicates that changes in the sample come only
from water, without a significant influence on the polymer
conformation.
EPS CG11 Exhibits Dose-Dependent
Antiedematous and Antihyperalgesic
Effects in the Model of
Carrageenan-Induced Paw Inflammation
The administration of EPS CG11 (3–5 mg/kg; i.p.) produced
a significant and dose-dependent reduction of carrageenan-
induced edema (p < 0.001). Maximal antiedematous effects were
observed from 60 to 90 min after carrageenan treatment and were
34, 51.3, and 58% for EPS CG11 doses of 3, 4, and 5 mg/kg,
respectively (Figure 3A).
In the case of hyperalgesia assessed by measuring PWT,
EPS CG11 (3–5 mg/kg; i.p.) caused a significant decrease
of carrageenan-induced mechanical hyperalgesia, in a dose-
dependent manner (p < 0.001). The peak antihyperalgesic effects
were achieved 60 min after carrageenan application and were
34.8, 42.2, and 46.5% for EPS CG11 doses of 3, 4, and 5 mg/kg,
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FIGURE 3 | The effects of EPS CG11 (EPS) on carrageenan (CAR)-induced paw edema (A) and mechanical hyperalgesia (B). The results are expressed as: (A) the
difference, in milliliters, between the post-treatment and basal paw volumes (dV) and (B) the difference, in grams, between basal and the post-treatment paw
withdrawal thresholds (df). EPS was administered i.p. 60 min before the CAR injection (denoted by arrows). Each point represents the mean ± SEM of dV (ml) or df
(g). Statistical significance (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; two-way repeated measures ANOVA followed by Tukey HSD test) was determined by comparison
with the curve of the control group. i.p., intraperitoneal; i.pl., intraplantar.
respectively (Figure 3B). Since the dose of 5 mg/kg produces the
most promising effect, it was chosen for further analysis.
The Expression of Inflammatory
Mediators in Rat’s Paw Tissue
Having in mind that EPS CG11 administration alleviated the
carrageenan-induced rat paw edema, we proceeded with the
analysis of gene expression of pro-inflammatory cytokines (TNF-
α, IL-1β, and IL-6) as well as iNOS to determine whether
the transcription of some of these genes could be potentially
altered by the EPS CG11. The effect of the EPS CG11 on gene
expressions in the rats paw tissue is presented in Figure 4.
As expected, the carrageenan injection in the rats paw tissue
significantly elevates mRNA levels of all tested genes compared
to saline administration. The mRNA expression of IL-1β and
iNOS genes in the paw tissues of rats treated with 5 mg/kg of
EPS CG11/carrageenan were significantly lower compared to the
expression levels of these genes in the rats injected only with
carrageenan (p < 0.05). More precisely, IL-1β expression showed
2.6 fold reduction when EPS CG11 was administered, while iNOS
mRNAs were reduced 1.7 times (Figures 4A,B). However, EPS
CG11 administration did not change the transcription levels
of TNF-α and IL-6 genes which retained a high mRNA levels
induced by carrageenan (Figures 4C,D). These results indicate
the potential of i.p. injected EPS CG11 to suppress inflammatory
response via regulation of IL-1β production on periphery.
Further, we assessed the expression of MPO, an enzyme used
as a marker of neutrophil recruitment and activation, and CD14,
a macrophages tissue marker. The results revealed the reduced
level of MPO enzyme and the elevated level of CD14 mRNA in
the paw tissue of animals co-treated with EPS CG11/carrageenan
compared to carrageenan controls, suggesting that i.p. injected
EPS CG11 suppress the function of neutrophils in the paw tissue,
but also pointed out the potential contribution of macrophages to
the suppression of inflammation (Figures 4E,F).
EPS CG11 Shows the
Immunosuppressive Properties in the
Peritonitis Model
To confirm our hypothesis on the regulation of cytokines
production by EPS CG11, a peritonitis model was used. As the
previous studies have reported, carrageenan caused the migration
of immune cells, predominantly neutrophils, into the peritoneal
cavity and the total cell number was significantly higher in the
animals receiving carrageenan relative to healthy control animals
(p < 0.05). However, the i.p. injection of EPS CG11 treatment
(5 mg/kg) did not affect carrageenan induced-immune cells
migration (Figure 5A). Additionally, in the contrast to the paw
tissue, i.p. injected EPS CG11 did not affect CD14 mRNA level
in the infiltrated cells induced by the carrageenan administration
(Figure 5D).
We further used the qPCR analysis to investigate the changes
in the expression of IL-1β, TNF-α, IL-6, and iNOS genes in the
infiltrated cells. Interestingly, the mRNA levels of IL-1β, TNF-
α, and iNOS in EPS CG11/carrageenan treated animals were
significantly lower compared to only carrageenan treated animals
(p< 0.01; p< 0.05; p< 0.01, respectively), while the transcription
of IL-6 gene was on the same level between these two groups of
animals (Figures 5B,C,E,F). In other words, the levels of IL-1β,
TNF-α and iNOS mRNAs was reduced for 2.4; 3 and 2 times,
respectively, compared to carrageenan controls.
The results of the ELISA measurements revealed that the
EPS CG11 administration led to the significant reduction of
high level of TNF-α induced by carrageenan (p < 0.05)
(Figure 5H). Interestingly, the higher levels of IL-10 and IL-6 in
peritoneal fluid in the animals treated both with EPS CG11 and
carrageenan compared to the animals received only carrageenan
or healthy control animals were detected (Figures 5G,I). Finally,
carrageenan itself has led to significantly higher levels of all three
cytokines, while in the healthy control animals the levels of IL-6
and TNF-α were under the detection limit (Figures 5G–I).
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FIGURE 4 | The expression of IL-1β (A), iNOS (B), TNF-α (C), IL-6 (D), and
CD14 (E) mRNAs and representative western blot and densitometric analysis
of MPO (F) in the paw tissue of the rats treated i.p. with 5 mg/kg of EPS
CG11 (EPS) 60 min before carrageenan (CAR) injection. All values are
expressed as mean ± SEM. One-way ANOVA with the Tukey’s post hoc test
were used to compare multiple groups (∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001). i.p., intraperitoneal.
Therefore, all the above mentioned results led us to conclusion
that immunosuppressive mediators were predominantly present
in the peritoneal cavity when EPS CG11 was administered.
DISCUSSION
A huge diversity of microbial world enables us to constantly
search new molecules with a potential to interact with the host
cells. Presently, between 20 and 50% of medications originate
from natural sources including bacteria (Kingston, 2011). Besides
antimicrobial molecules usually found in bacteria, cell surface
macromolecules as well as bacterial metabolites have been
extensively studied due to their key role in the interaction
with host receptors (Dinic et al., 2017). Different modifications
(e.g., glycosylation) of surface molecules and/or the presence
of strain exclusive molecules (e.g., EPSs) dictate strain specific
effects, which explain applications of numerous bacterial strains
as probiotics (Lebeer et al., 2010; Zivkovic et al., 2016). It’s well-
documented that EPS production is involved in the probiotic
beneficial effects. Therefore, in the light of rising application of
bacterial EPSs, here we demonstrate the novel ability of EPS
CG11 to suppress a pain sensation via regulation of inflammatory
response.
Previous studies reported that strain L. paraplantarum
BGCG11 produces ropy, big-size polymer around 2 × 106 Da,
mainly composed of glucose and rhamnose with the traces
of galactose and mannose, but further information regarding
stability of the polymer is missing (Cerning et al., 1994; Zivkovic
et al., 2015). As one of the important steps in drug design and
development is the investigation of thermal behavior of new
molecules in order to collect stability information for adequate
pharmaceutical processing (Shamsipur et al., 2013). According
to the literature data, the thermal stability of EPSs from various
bacterial sources may vary. The TGA curve of EPS CG11
showed that maximal degradation temperature of the polymer
was 250.3◦C, while the overall mass loss at the end of the
analysis was 72.7%. This is in accordance with the decomposition
temperature reported for EPSs isolated from L. plantarum and
L. kefiranofaciens (Wang et al., 2010; Ahmed et al., 2013). On
the other hand, low enthalpy values (7–11 j/g) of EPS CG11
measured in DSC analysis, confirmed that this EPS molecule did
not undergo phase transition processes unlike KF5 EPS produced
by L. plantarum which melting temperature was 86.35◦C, with
the enthalpy value of 133.5 J/g (Ahmed et al., 2013). These
different observations in the thermal behavior of these two EPSs
could be explained by different structures and monosaccharide
composition of the polymers. Hence, it can be said that EPS CG11
possesses good thermal properties and could undergo through
various technological processing where temperature reach 150◦C
(Ahmed et al., 2013).
It has been shown that the crude polysaccharides as well as
sulfated ones isolated from lichens and seaweeds exhibit potential
to alleviate inflammatory pain in rodents by suppressing IL-
1β and/or TNF-α production (Chaves et al., 2013; Córdova
et al., 2013). The results obtained in our study are in
accordance with the literature data regarding the polysaccharide
application as pain relief agents. The dose-dependent reduction
of pain sensations as well as paw edema was noticed after
the administration of EPS CG11 in carrageenan-induced paw
inflammation in rats. The carrageenan administration evokes
biphasic edema. The first phase of edema last for 1 h and
is reflected in the release of histamine, bradykinin, serotonin
and cyclooxygenase products (8-iso-prostaglandin F2α; 8-iso-
PGF2α and prostaglandin E2; PGE2). During the second phase,
which last for the next 2 h, neutrophil infiltration, the liberation
of cytokines and NO occur, while prostaglandins production
continue (Vinegar et al., 1969; Ozdol and Melli, 2004). Taking
into account that the effect of EPS CG11 was the strongest for 2 h
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FIGURE 5 | Assessment of immunosuppressive properties of EPS CG11 in the peritonitis model. The number of cells infiltrated in the peritoneal cavity (A),
expression of IL-1β (B), iNOS (C), CD14 (D), TNF-α (E), and IL-6 (F) mRNAs in the peritoneal cells and the levels of IL-10 (G), TNF-α (H), and IL-6 (I) cytokines in the
peritoneal fluid after i.p. administration of 5 mg/kg of CG11 EPS (EPS) 60 min before i.p. carrageenan (CAR) injection. The results are presented as means ± SEM.
For the comparison of multiple groups, one-way ANOVA with the Tukey’s post hoc test were used (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). i.p., intraperitoneal.
after the carrageenan administration we could assume that EPS
CG11 influences both phases of inflammation.
Based on these findings, we analyzed the influence of EPS
CG11 on a release of inflammatory mediators important for
hyperalgesia and inflammation. Numerous studies focused on
the pro-inflammatory cytokines showed that injections of TNF-α,
IL-1β, and IL-6 produce both mechanical and thermal
hyperalgesia. On the other hand, a release of potent anti-
inflammatory cytokine IL-10 attenuates spinally mediated
pain, counter-regulating the synthesis of pro-inflammatory
cytokines (Zhang and An, 2007). In the paw tissue of
EPS CG11/carrageenan treated rats, EPS CG11 caused a
downregulation of IL-1β and iNOS mRNA levels, while the
levels of TNF-α and IL-6 mRNAs were not changed compared to
carrageenan controls. The same effect was observed by Córdova
et al. (2013) reporting that the analgesic effect of glucomannan
depended on the inhibition of IL-1β release, without the affection
of TNF-α production in the sciatic nerve. Additionally, as the
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transcription of iNOS gene is regulated by IL-1β (Pautz et al.,
2010), the decrease in iNOS mRNA levels measured in the
paws of animals treated with EPS CG11/carrageenan compared
to carrageenan controls is probably the consequence of IL-
1β downregulation. Taking into account that the expression
of cyclooxygenase-2 (COX-2), which is responsible for the
synthesis of prostaglandins (8-iso-PGF2α and PGE2) during
the first phase of carrageenan inflammation, is stimulated
by IL-1β production, we could assume that the decreased
level of IL-1β mRNA caused by EPS CG11 contributed to
its anti-inflammatory effect by acting on the prostaglandins
synthesis in the beginning of the inflammatory process (Molina-
Holgado et al., 2000). Also, the decreased MPO level detected
in the paw tissue in the group of animals receiving EPS
CG11/carrageenan suggested that anti-inflammatory effect of
EPS CG11 could be the consequence of impaired neutrophils’
function in the paw.
In order to understand the role of EPS CG11 in the
modulation of cytokines’ production we additionally used
the carrageenan-induced peritonitis model suitable for the
investigation of leukocyte migration (Barth et al., 2016). As was
noticed in the paw tissue, the expression of IL-1β and iNOS
mRNAs showed approximately the same level of reduction in
the peritoneal cells after EPS CG11/carrageenan administration
compared to carrageenan controls. Additionally, level of TNF-
α, as well as the transcription of TNF-α gene, was significantly
reduced in the same group of animals, together with the
increased level of anti-inflammatory cytokine IL-10. In the case of
IL-6, which is categorized as either anti-inflammatory or pro-
inflammatory cytokine, under various circumstances (Zhang
and An, 2007), there is a discrepancy between its mRNA
and protein level in peritoneum of EPS CG11/carrageenan
treated rats. Although, the protein level of IL-6 was elevated
in the peritoneum, the mRNA level was unchanged and in
accordance with that obtained in the paw tissue. Given that,
the cell infiltration in the peritoneal cavity was the same
irrespectively of EPS CG11 treatment, it could be concluded
that the reduction of pro-inflammatory cytokines was not
related to lower infiltration of neutrophils. A similar effect
was exhibited by cyanidin-3-glucoside, an anthocyanin, when
administered prophylactically, as we did with EPS CG11, in the
carrageenan-induced peritonitis model (Hassimotto et al., 2013).
More precisely, the authors noted that cyanidin-3-glucoside
given 30 min before carrageenan alleviated inflammation by
suppressing COX-2 expression and PGE2 synthesis, with no effect
on neutrophil influx.
Further, the elevated level of CD14 mRNA in the rat
hind paw, pointed to the possibility that EPS CG11 exhibits
its anti-inflammatory effect by acting on macrophages.
Therefore, based on the higher secretion of IL-10 and the
lower levels of IL-1β and iNOS mRNAs observed in EPS
CG11/carrageenan treated rats in the peritonitis model, it could
be assumed that the intraperitoneal injection of EPS CG11
probably influenced the peritoneal macrophages to acquire
the immunosuppressive properties. Together with the report
of Bhaumik et al. (2001) that macrophages migrate from the
peritoneal cavity to the subcutaneous tissue, above results suggest
the potential involvement of peritoneal macrophages in the
resolution of paw inflammation. However, as neutrophils also
express CD14 molecule, this hypothesis about macrophages
infiltration/migration needs to be confirmed in further
experiments. Altogether, the differences in cytokine production
and the cells migration between the paw tissue and the peritoneal
cavity are most probably due to the differences of EPS CG11
and carrageenan application route in these two models of
inflammation. So, in the inflammatory pain model, only cells
that are exposed to the EPS CG11 are those migrating from the
peritoneum, while all other cells in the inflamed paw are exposed
only to carrageenan. At contrary, in model of peritonitis, resident
as well as all infiltrated cells are exposed to the EPS CG11 and
carrageenan simultaneously.
Finally, considering the results obtained in this study, we can
conclude that EPS CG11 is highly promising antihyperalgesic
molecule with good physico-chemical properties which makes
it a potential candidate for further investigation and drug-
development.
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